Acta Neuropathol Commun June 2023 PMID 37331971

Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.

Ksenija Martinović, Jan Bauer, Markus Kunze, Johannes Berger, Sonja Forss-Petter

Download social card

Mentions

5
Peak: 1 in Jun 2023
across 3 sources since Jun 2023

Extended reach

3,108
potential audience

Total likes

0

Video views

23

Mentions per month

Jun 2023 – Jan 2025

Where it's discussed

  • X / Twitter2 posts
  • Facebook2 posts
  • YouTube1 videos

AI synopsis

What people are saying

The overall conversations reflect a moderate engagement with the findings, primarily through sharing links and noting the significance of the research. Words like 'new from' and phrases such as 'read more' suggest intellectual curiosity and a desire to explore the study further, without highly charged language or strong opinions. This indicates a neutral and interested attitude toward the publication’s content and potential implications.

AgreementNeither agree nor disagree

The discussions show a neutral stance, with no clear support or disagreement for the findings.

InterestModerate interest

There is a mild interest expressed, especially from those highlighting new research or open access articles.

EngagementModerate engagement

Participants are engaging by sharing links and discussing the article’s relevance, indicating some level of engagement.

ImpactModerate impact

The shared content suggests the research is recognized as potentially influential, but lacks strong emphasis on immediate impact.

Abstract in brief

  • Abcd1 deficiency in a mouse model of X-linked adrenoleukodystrophy (XALD) increases vulnerability of mature oligodendrocytes and causes more axonal damage during cuprizone-induced demyelination, suggesting a primary role of oligodendrocytes in disease pathology.
  • The study found that the absence of ABCD1 leads to accumulation of very long-chain fatty acids, which heightens the susceptibility of oligodendrocytes to cell death and nerve fiber damage during demyelination, without significantly altering microglial activity or the capacity for remyelination.
  • These results imply that oligodendrocyte loss and axonal injury in XALD may be directly linked to cell-autonomous effects of VLCFA buildup, rather than inflammatory processes or microglial dysfunction, highlighting potential targets for therapeutic intervention.]

Top posts

Most liked on X and Bluesky
Europe PMC articles
@EuropePMC · X

New from #FWFOpenAccess https://t.co/ORPsZjIJLe Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.

Jun 21, 2023 · 1,553 followers View post →
Jackson ImmunoResearch
@JacksonImmunoR · X

Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy - Acta Neuropathologica Communications. Read more with this article #JIRSecondaryAntibodies https://t.co/tqu5nBbdUh

Jan 12, 2025 · 1,533 followers View post →

All mentions

Jackson ImmunoResearch
@JacksonImmunoR · X

Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy - Acta Neuropathologica Communications. Read more with this article #JIRSecondaryAntibodies https://t.co/tqu5nBbdUh

Jan 12, 2025 · 1,533 followers View post →
Europe PMC articles
@EuropePMC · X

New from #FWFOpenAccess https://t.co/ORPsZjIJLe Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.

Jun 21, 2023 · 1,553 followers View post →